RPS9

RPS9 (uS4) is a structural protein of the small ribosomal subunit that governs translational fidelity and supports small subunit biogenesis (PMID:28483689). Its C-terminal domain is required for both accurate mRNA decoding and proper subunit assembly, with C-terminal truncations causing increased miscoding, defective small subunit assembly, and impaired rRNA processing; the assembly requirement is less stringent than the decoding requirement, and the relevant decoding function maps to the uS4–uS5 interface (PMID:28483689). This interface is dynamically tuned by an evolutionarily conserved phosphoserine–arginine salt bridge: Ypk2 directly phosphorylates uS5-Ser176, which pairs with uS4-Arg57 to strengthen the interface and raise codon selection fidelity, while a competing TORC1–Pkc1 pathway opposes this effect, so accuracy emerges from the balance between two kinase pathways (PMID:38340338). RPS9 expression is autoregulated: in yeast and Drosophila, intron-dependent cross-regulation and alternative splicing coupled to NMD repress excess RPS9 transcripts, analogous to prokaryotic S4/alpha-operon autorepression (PMID:22479208). At the organismal level, loss of rps9 in zebrafish impairs erythrocyte maturation and causes p53-dependent anemia that is partially rescued by L-leucine and dexamethasone (PMID:31619461). Beyond its ribosomal role, RPS9 protein stability is positively regulated by physical interaction with LAPTM4B, an interaction that drives STAT3 activation and leukemia progression (PMID:36758682), and RPS9 also physically binds the lncRNA BRCAT54 in a feedback loop modulating JAK-STAT and calcium signaling (PMID:32459848).

1. 2012 Medium

   Established that RPS9 expression is self-limiting through an intron-mediated autoregulatory circuit, answering how cells balance the levels of a ribosomal protein and revealing an evolutionarily conserved analog of prokaryotic S4 autorepression.

   Evidence Precise intron deletion in S. cerevisiae paralogs, exogenous overexpression in Drosophila S2 cells, and comparative EST analysis across eukaryotes

   PMID:22479208

   Open questions at the time

   • Does not demonstrate the human RPS9 autoregulatory mechanism directly
   • The molecular trigger linking excess protein to splicing/NMD is not resolved
2. 2017 Medium

   Defined the C-terminus of uS4/RPS9 as the structural element required for both decoding accuracy and small subunit assembly, and corrected prior misclassification of Salmonella mutants by showing they are error-prone, tying fidelity to the uS4–uS5 interface.

   Evidence In vivo miscoding assays, intragenic suppressor isolation, ribosome assembly and 16S rRNA processing assays, and reconstruction of Salmonella mutants in E. coli/Salmonella

   PMID:28483689

   Open questions at the time

   • Performed in bacterial systems; eukaryotic equivalence not directly tested here
   • Does not resolve how the interface mechanistically controls codon selection
3. 2017 Low

   First linked RPS9 to cancer cell proliferation and MAPK signaling, raising the question of an extra-ribosomal signaling role.

   Evidence RNAi knockdown in three osteosarcoma cell lines with PathScan antibody array, western blotting, and proliferation/colony assays

   PMID:28928861

   Open questions at the time

   • No direct mechanistic link between RPS9 and MAPK established; no rescue or epistasis
   • Cannot separate ribosomal from non-ribosomal effects of knockdown
4. 2019 Medium

   Showed that RPS9 loss produces a defined erythroid phenotype in vivo through a p53-dependent pathway, connecting the ribosomal protein to a ribosomopathy-like anemia.

   Evidence Zebrafish rps9 mutant cytomorphology, hemoglobin analysis, p53 genetic epistasis, and pharmacological rescue with L-leucine and dexamethasone

   PMID:31619461

   Open questions at the time

   • Molecular basis of p53 activation downstream of rps9 loss not defined
   • Mechanism of L-leucine/dexamethasone rescue unresolved
5. 2021 Medium

   Identified RPS9 as a direct binding partner of the lncRNA BRCAT54 in a feedback loop regulating JAK-STAT and calcium signaling, providing reciprocal evidence for an extra-ribosomal regulatory function.

   Evidence RNA pull-down, RIP, RNAi knockdown, microarray, qRT-PCR, and rescue assays in NSCLC cells

   PMID:32459848

   Open questions at the time

   • Structural basis of the RNA-protein interaction not defined
   • How RPS9 mechanistically modulates JAK-STAT/calcium genes unknown
6. 2022 Low

   Positioned RPS9 upstream of STAT3 and ERK activation in NSCLC, extending its proposed signaling role to tumor proliferation, metastasis, and apoptosis.

   Evidence RNAi knockdown and overexpression in NSCLC lines, antibody array, phospho-STAT3/ERK western blotting, and CCK-8/colony/transwell/flow cytometry assays

   PMID:35281852

   Open questions at the time

   • No direct mechanistic link between RPS9 and STAT3/ERK
   • Signaling effects not separated from global translation changes
7. 2023 Medium

   Demonstrated that LAPTM4B physically interacts with and stabilizes RPS9 protein to drive STAT3-dependent leukemia progression, giving the first physical-partner mechanism for an extra-ribosomal RPS9 function.

   Evidence Co-immunoprecipitation, protein stability assays, STAT3 activation readout, and in vitro/in vivo leukemia progression assays in AML

   PMID:36758682

   Open questions at the time

   • Reciprocal interaction validation and interaction interface not defined
   • How stabilized RPS9 activates STAT3 mechanistically unresolved
8. 2024 High

   Resolved at residue resolution how translational accuracy is tuned at the uS4–uS5 interface, showing Ypk2 phosphorylates uS5-Ser176 to form a salt bridge with uS4-Arg57 while a competing TORC1–Pkc1 pathway opposes it.

   Evidence Site-directed mutagenesis of uS4-Arg57 and uS5-Ser176, in vivo translational accuracy assays, and multi-kinase epistasis in S. cerevisiae

   PMID:38340338

   Open questions at the time

   • Conservation of this regulatory salt bridge in human ribosomes not tested directly
   • How the two kinase pathways integrate physiological signals to set fidelity not defined

• It remains unknown how RPS9's canonical ribosomal/decoding function mechanistically connects to its reported extra-ribosomal signaling roles (STAT3, ERK, MAPK, JAK-STAT) in cancer cells.
• No experiment separates ribosomal-pool depletion from a dedicated signaling function
• No structural or biochemical mechanism linking RPS9 to specific kinase activation
• Human-specific autoregulation and interface phosphorylation not directly demonstrated